Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy is a research paper published in Clinical Pharmacology & Therapeutics (2021). On theSindex it has a DataRank of 0. It has been cited 408 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Health and Medical Research Council
Grant: 1011251
NIDA NIH HHS
Grant: R01 DA042985
NHGRI NIH HHS
Grant: U01 HG008666
NHGRI NIH HHS
Grant: U01 HG011172
NHGRI NIH HHS
Grant: U24 HG010135
NHGRI NIH HHS
Grant: U01 HG007269
NCATS NIH HHS
Grant: UL1 TR001427
NIGMS NIH HHS
Grant: R35 GM124939
NHGRI NIH HHS
Grant: U24 HG010615
NCATS NIH HHS
Grant: UL1 TR001082
NCATS NIH HHS
Grant: UL1 TR002535
NIGMS NIH HHS
Grant: R24 GM123930
NHGRI NIH HHS
Grant: U01 HG010245
National Institutes of Health
National Institutes of Health (NIH)
National Institutes of Health (NIH)
FWCI
46.67
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals